Use of Psychotropic Medications in Older Adults with Dementia!

Similar documents
Psychotropic Medication Use in Dementia

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

Medications and Children Disorders

Introduction to Drug Treatment

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Guide to Psychiatric Medications for Children and Adolescents

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

PSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Antidepressants. Dr Malek Zihlif

South London and the Maudsley NHS Foundation Trust Medicines Formulary

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.

Appendix: Psychotropic Medication Reference Tables

Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

NorthSTAR. Pharmacy Manual

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Study Guidelines for Quiz #1

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

DEMENTIA AND MEDICATION

MO Medicaid Foster Care Drugs FY10-FY14

Schedule FDA & literature based indications

The use of prescription psychotropic medication in

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Index. E Elderly and dementia, 2 Epilepsy, 59 Escitalopram, 51, 87 Estazolam, 101 Extrapyramidal symptoms (EPS), 18

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Antipsychotics for Dementia Under Control or Over-Prescribed?

Antipsychotic Use in the Elderly

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources

Management of Behavioral Problems in Dementia

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

Retrospective Drug Use Review for the Use of Psychotropic Medications in Children

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

Psychobiology Handout

Policy Evaluation: Low Dose Quetiapine Safety Edit

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Joint Formulary for Psychotropic Medication.

Prescriber s Guide. Stahl s Essential Psychopharmacology

This document has been produced in collaboration with the Lancashire Commissioning Support Unit

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018

Psychiatric Medication Guide

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence

BIOLOGICAL TREATMENT IN PSYCHIATRY. PTE ÁOK Dept.of Psychiatry Pécs

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

Mood Disorders.

2015 Update on Psychotropics

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Pharmacological Treatment of Anxiety & Depressive Disorders

Any interventions, where RCTs in PD are not available, are not included in the tables.

Insomnia: Updates in Medical Management. Michael Newnam M.D.

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.

Chapter 161 Antipsychotics

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

Depression in Late Life

Katee Kindler, PharmD, BCACP

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Medications, By Class, in TBI

How did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh

PSYCHIATRY INTAKE FORM

BEHAVIORAL PROBLEMS IN DEMENTIA

Treatment Options for Bipolar Disorder Contents

Medicine Related Falls Risk Assessment Tool (MRFRAT)

Psychiatric Medications. Positive and negative effects in the classroom

Treating Anxiety Disorders. Adil Virani, BSc (Pharm), Pharm D, FCSHP

10/5/2017. BEHAVIORAL and PSYCHOLOGICAL SYMPTOMS in DEMENTIA (BPSD) Dr. Shah MD, MPH Braodlawns Medical Center DISCLOSURE

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling

med ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors.

Anti-Depressant Medications

Professor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065

Dealing with a Mental Health Crisis

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?

Mentoring Session: Participant Cases

Updates in Geriatric Psychiatry

Medicines Formulary BNF Section 4 Central Nervous System

Psychotropic Strategies Handout Package

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

The Road to Rehabilitation

9/17/2015 DIAGNOSTIC PUZZLES LEARNING OBJECTIVES MENTAL ILLNESS MEDICAL COMORBIDITIES

Understanding Alzheimer s Disease

A Basic Approach to Mood and Anxiety Disorders in the Elderly

HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE

USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE?

Disclosure. Objectives: Technician. Objectives: Pharmacist. Diagnostic and Statistical Manual (DSM-V) The Face of Mental Illness 7/25/2015

Depression in Older Adults. Paul Boulware, MD Arizona Neurological Institute April 22, 2012

Drug Name Class Examples Mechanism Uses Side Effects Notes Monoamine Oxidase Inhibitors (rarely used)

New Patient Questionnaire

SAMPLE REPORT MENTAL HEALTH DNA INSIGHT LABORATORY INFO. Protected Health Information. SSRIs. TCAs. Other Antidepressants

Anxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif

Transcription:

Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775

About Me Deepa Pattani, PharmD, RPh with over 13 years of experience as a Pharmacist Practiced in various aspects of pharmaceutical care Licensed to practice in 4 states throughout the country Contact info: Deepa.Pattani@PrevInteract.com 972-372-9775

Introduction: Dementia Dementia: decline in mental ability severe enough to interfere with daily activities. 2015: 47.47 million individuals affected worldwide. Alzheimer s dementia accounts for 60-80% of all dementia cases. Vascular dementia: occurs after stroke: 2 nd most common type of dementia. 15 million people provide unpaid care for people with dementia: 18.2 billion hours: $230 billion. Incorrectly labeled senile dementia and not a part of the normal aging process. 2017 cost to nation: $257 billion

Agenda After completion of this activity, the target audience should be able to: Describe different types of dementia and methods of identification. Describe at least 2 classes of psychotropic medications used in the treatment of dementia. Recognize side effects of psychotropic medications vs. symptoms of disease progression. Clinically determine how to screen a patient that may need medications or behavior modifications.

Types of Dementia Alzheimer s disease: difficulty remembering. Vascular dementia: impaired ability to make decisions. Dementia with Lewy bodies (DLB): early symptoms: sleep disturbance, visual hallucinations. Mixed dementia: multiple dementia symptoms seen. Parkinson s disease: gait disturbances.

Types of Dementia (contd) Frontotemporal dementia: behavior problems & difficulty with language. Creutzfeldt- Jacob disease: rapidly fatal: memory loss, coordination & behavior changes. Huntington s disease: involuntary movements, severe decline in reasoning, depression, mood changes. Normal pressure hydrocephalus: memory loss, loss of bladder control. Wernicke-Korsakoff syndrome: memory loss due to severe thiamine deficiency: alcohol misuse.

Treatment No treatment for dementia currently. Medications and non-drug therapy used in combination. Dietary supplements.

Psychotropic Medications Antidepressants Anxiolytics, sedatives and hypnotics Stimulants Mood stabilizers Neuroleptics Cognitive enhancers/ stabilizers

Psychotropics: Anti-depressants SSRIs: Fluvoxamine, Fluoxetine, Paroxetine, Citalopram, Sertraline, Escitalopram All Ages GI upset Serotonin Syndrome Akathisia Hyponatremia Older Adults Falls/ Hip fractures QTc prolongation (Celexa) Osteoporosis Anticholinergic side effects Increase risk of bleeding (anticoagulants)

Anti-depressants (contd) SNRIs Venlafaxine, Duloxetine TCAs Amitriptyline, Clomipramine, Desipramine, Doxepin, Imipramine, Nortriptyline, Protriptyline, Trimipramine MAOIs Isocarboxacid, Phenelzine, Selegiline (oral and patch), Tranylcypromine Misc Mirtazapine, Trazodone, Bupropion.

Psychotropics:Anxiolytics SSRIs, SNRIs, TCAs, and MAOIs Benzodiazepines Miscellaneous Buspirone, trazodone Propranolol, clonidine Antihistimines Antiepileptics (AEDs)

Psychotropics: Anxiolytics Benzodiazepines Long acting: Chlordiazepoxide, Clonazepam, Diazepam, Flurazepam & Quazepam. Intermediate-acting: Alprazolam, Oxazepam, Lorazepam, Clonazepam. Short-acting: Triazolam, Midazolam, & chlorazepate

Anxiolytics: Benzodiazepines Side-effects: FALL risk greatly increased. CONFUSION, CONFUSION, CONFUSION!!! Paradoxical reactions More likely to have withdrawal symptoms (and to have these symptoms misrecognized) Dementia: very hard to differentiate if effects are from BZDs or dementia. (Risk of mis-diagnosis) Depression Misuse

Psychotropics: Anxiolytics Miscellaneous Buspirone Trazodone: mild anticholinergic effects, sedation Propranolol, clonidine: hypotension, can potentially address 2 problems with 1 medication Antihistamines: anticholinergic side-effects

Psychotropics: Sedative/Hypnotics Benzodiazepines Non-benzodiazepine hypnotics: Falls, confusion, misuse Zolpidem Zaleplon Eszopiclone Melatonin receptor agonist: Ramelteon: well-tolerated Miscellaneous: Trazodone, mirtazapine, and chloral hydrate (effects similar to alcohol)

Psychotropics: Stimulants Used for apathy, amotivation, depression Worsen anxiety Buproprion: Anticholinergic properties Methylphenidate: tachycardia, hypertension, confusion, hallucinations

Psychotropics: Mood Stabilizers May be useful for impulsivity and irritability Divalproex, valproic acid, valproate: dizziness, falls, elevated liver enzymes, elevated ammonia, weight gain, hair loss. Carbamazepine: blood dyscrasias, elevated liver enzymes, interactions with other medications

Psychotropics: Neuroleptics Typical (first generation): Chlorpromazine, thioridazine, trifluoperazine, fluphenazine, perphenazine, prochlorperazine, thiothixene, loxapine, pimozide, haloperidol Atypical (second generation): Clozapine, risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole

Neuroleptics Appropriate Indication Acute psychotic episode, atypical psychosis, brief reactive psychosis Delusional disorders Schizophrenia, schizo-affective disorder Huntington s disease Mood disorder w/ psychotic features Tourette s syndrome Dementia & delirium with agitated behaviors Short term (< 7 days): hiccups, pruritic, nausea & vomiting Inappropriate Use Agitated behaviors that is not a threat to patient or others Depression without psychosis Anxiety, nervousness Fidgeting, restlessness, wandering Impaired memory Indifference to surrounding, poor self care/hygiene Unco-operativeness, unsociability Insomnia

Neuroleptics: cont d Weight gain All Ages Diabetes/ metabolic syndrome Akathesia Sedation Dystonic reactions Older Adults Sudden death (Black Box Warning) EPS, Parkinsonism Cardiac dysrhythmias Anticholinergic effects Hyponatremia Seizures

Neuroleptics: Black Box Warning Increased risk of death when used in elderly patients treated for dementia-related psychosis

Psychotropics: Cognitive Enhancers Acetylcholinesterase inhibitors Donepezil, galantamine, rivastigmine Side effects: GI, vivid dreams (donepezil) Peripheral cholinergic side effects (cardiac) NMDA antagonist: Memantine GI side-effects, paradoxical agitation

Cognitive Enhancers (cont d) FDA approval Alzheimer s disease/dementia Beneficial in vascular dementia, dementia related to Parkinson s disease, and perhaps in some FTD Beneficial in neuropsychiatric symptoms of dementia!

Neuroleptics Common side effects: EPS (akathisia, dystonia, pseudoparkinsonism, dyskinesia), sedation, and orthostatic hypotension Long term use of drugs such as Haldol, Risperdal, Zyprexa increase risk of falls by 81%. Recommended to use the smallest possible dose for the shortest duration of action.

Drug Selection Appropriate and documented diagnosis associated with medication being prescribed. Document trials of behavioral management. Document assessment of medication s side effects. Document benefit of medication. Documentation of dose reduction trial. Explanation for continued medication.

Clinical Decision Making: Side-effect vs. Symptom Management What is the issue/behavior? What might be causing it or contributing to it? Is there a way to quantify or measure the degree of symptomatology (e.g., a screening instrument)? Is it an issue that can be completely or partially addressed without medication?

Clinical Decision Making: Side-effect vs. Symptom Management Non-drug symptom management Monitor personal comfort. Avoid being confrontational. Redirect the person's attention (use of art/ music). Create a calm environment. Allow adequate rest Provide a security object. Acknowledge requests, and respond to them. Look for reasons behind each behavior.. Explore various solutions. Don't take the behavior personally.

Clinical Decision Making: Sideeffect vs. Symptom Management Supplements used for dementia patients: Ginger Gingko biloba Omega 3 fatty acids Vitamin C Curcumin

Clinical Decision Making: Side-effect vs. Symptom Management So, a medication is needed Is there a current medication that can be adjusted to address the behavior? What are the individual s comorbidities and do they prevent the use of any medications? What are the most benign medications that can be used? Are there any side effect profiles that can be useful?

Clinical Decision Making: Side-effect vs. Symptom Management Once a medication has been selected: Monitor and document response of symptoms. Monitor and document screening for side effects (e.g., sodium, falls, AIMS). Periodically conduct trials of a decreased dose. Try tapering off the medication to determine if it s still needed.